| Dr Andy Yen-tang Lee, MD | |
|
101 The City Dr S, Orange, CA 92868-3201 | |
| (714) 456-7890 | |
| Not Available |
| Full Name | Dr Andy Yen-tang Lee |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 5 Years |
| Location | 101 The City Dr S, Orange, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013250463 | NPI | - | NPPES |
| AL3232267556 | Other | AL3232267556 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A135643 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of California Irvine Medical Center | Orange, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uc Regents | 7416869516 | 205 |
News Archive
American Scientists have managed to edit and improve the DNA of human embryos in an effort to correct the gene defects that cause inherited diseases.
Los Angeles County officials are questioning the "cost-effectiveness of rules aimed at screening those trying to get public health services," The Los Angeles Times reports. The county began implementing tougher federal standards in 2008, receiving "nearly $28 million in state and federal funds to cover the cost of the program and posted 81 people in 27 social service department offices to check documents."
An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.
Each year nearly 600,000 people-mostly children under age five and pregnant women in sub-Saharan Africa-die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species-Plasmodium falciparum-has proven notoriously resistant to treatment efforts.
› Verified 5 days ago
| Entity Name | Uc Regents |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760430847 PECOS PAC ID: 7416869516 Enrollment ID: O20031118000906 |
News Archive
American Scientists have managed to edit and improve the DNA of human embryos in an effort to correct the gene defects that cause inherited diseases.
Los Angeles County officials are questioning the "cost-effectiveness of rules aimed at screening those trying to get public health services," The Los Angeles Times reports. The county began implementing tougher federal standards in 2008, receiving "nearly $28 million in state and federal funds to cover the cost of the program and posted 81 people in 27 social service department offices to check documents."
An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.
Each year nearly 600,000 people-mostly children under age five and pregnant women in sub-Saharan Africa-die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species-Plasmodium falciparum-has proven notoriously resistant to treatment efforts.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andy Yen-tang Lee, MD 200 S Manchester Ave Ste 300, Orange, CA 92868-3219 Ph: (714) 456-2986 | Dr Andy Yen-tang Lee, MD 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-7890 |
News Archive
American Scientists have managed to edit and improve the DNA of human embryos in an effort to correct the gene defects that cause inherited diseases.
Los Angeles County officials are questioning the "cost-effectiveness of rules aimed at screening those trying to get public health services," The Los Angeles Times reports. The county began implementing tougher federal standards in 2008, receiving "nearly $28 million in state and federal funds to cover the cost of the program and posted 81 people in 27 social service department offices to check documents."
An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.
Each year nearly 600,000 people-mostly children under age five and pregnant women in sub-Saharan Africa-die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species-Plasmodium falciparum-has proven notoriously resistant to treatment efforts.
› Verified 5 days ago
Michael Cheng, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7110 | |
Harry Nguyen, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7002 | |
Millie Arora, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, City Tower, Suite 400, Orange, CA 92868 Phone: 714-456-5691 Fax: 714-456-8874 | |
Dr. Sarah Jeanette Ettinger, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5135 | |
Dr. Antonio Halais Frangieh, MD, MPH Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 | |
Dr. Jesse John Goitia Jr., M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 |